Risky Business, or Is It?

Biologist Marston Bates once described research as “the process of going up alleys to see if they are blind.” Bates was referring to the inherent uncertainty in predicting and managing the scientific process. Research funding, particularly for fundamental science, can be a seemingly risky investment because of the uncertainty of a study’s impact. However, it is imperative that fundamental science is not viewed as a luxury, but as a necessary investment that has the potential to yield significant returns.

Continue reading

Should you trust that article you’re reading?

It’s easy to find information on the internet — especially information that confirms what you already believe to be true. Through search engine bias, your Facebook newsfeed bubble, and confirmation bias, we can unknowingly surround ourselves with a cozy blanket of comforting information. Whether or not this information is true, however, is a different story. Check out this infographic for some strategies for how to know if what you’re reading is true.Continue reading

The Consequences of Illusory Superiority

On January 6, 1995, a large five-foot-six 270-pound middle-aged man robbed two Pittsburgh banks in broad daylight. He didn’t wear a mask or any sort of disguise. And he smiled at surveillance cameras before walking out of each bank.

Later that night, police arrested a surprised McArthur Wheeler. When they showed him the surveillance tapes, Mr. Wheeler stared in disbelief. “But I wore the juice,” he mumbled.Continue reading

Science Advocacy on Capitol Hill: Bridging the Legislative Gap to Medical Research Funding

Last Thursday, September 17th I had the privilege of joining over 300 organizations including patients, physicians and fellow researchers in the Rally for Medical Research on Capitol Hill. Now in the third year of gathering to raise awareness for medical research, we met with Congressional representatives and staff from 40 states to demand “robust, sustainable and predictable funding increases for the NIH (National Institutes of Health)” in the coming fiscal year and beyond.Continue reading